Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
Antineoplastic Combined Chemotherapy Protocols
Both arms of RTOG 0113 were associated with high morbidity, and the study did not meet its 1-year survival end point.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency